Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Are compounded weight-loss drugs the next opioid crisis? Inside the unregulated boom of off-label GLP-1s Are GLP-1 weight-loss drugs like semaglutide fueling a new safety crisis? Explore the unregulated boom in compounded injections and FDA’s crackdown. byPallavi MadhirajuSeptember 12, 2025